The largest database of trusted experimental protocols

Next seq 550 apparatus

Manufactured by Illumina
Sourced in United States

The NextSeq 550 is a next-generation sequencing system designed for a wide range of applications, including gene expression analysis, targeted resequencing, and small RNA sequencing. The system utilizes sequencing-by-synthesis technology to generate high-quality sequencing data. The NextSeq 550 is capable of producing up to 120 gigabases of data per run, with read lengths up to 150 base pairs. The system features a user-friendly interface and is compatible with a variety of library preparation kits and analysis software.

Automatically generated - may contain errors

2 protocols using next seq 550 apparatus

1

Nuclei and Nucleoli Isolation and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nuclei and nucleoli were isolated as previously described (Pontvianne et al. 2016a ) using a S3 cell sorter (Biorad®) at the Bioenvironment cytology platform (Perpignan University, Perpignan, France). Sorted nuclei or nucleoli were treated with RNase A and proteinase K prior to phenol/chloroform DNA purification, followed by two precipitation steps. DNA libraries were generated via the kit Nextera XT DNA sample preparation (Illumina®) according to manufacturer's instructions and were, then, subjected to high throughput paired-end 2X150nt sequencing on a Next-seq 550 apparatus (Illumina ®) at the Bioenvironment sequencing platform (Perpignan University, Perpignan, France). NADs identification was then performed as described in (Carpentier et al. 2018) (link). DNA-seq data are deposited at the ENA European Nucleotide Archive under the reference PRJEB36061.
+ Open protocol
+ Expand
2

RNA-seq Analysis of Triple-Negative Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using RNA extracted in 2.2.2.2., cDNA libraries were prepared with Illumina Stranded mRNA Prep, Ligation kit (Illumina, Inc., San Diego, CA, USA) according to the manufacturer’s instructions. Paired-end read (2 × 74 bp) RNA sequencing (RNAseq) was performed on a NextSeq 550 apparatus (Illumina) with a NextSeq 500/550 Mid Output Kit v2.5 (Illumina, Inc., San Diego, CA, USA). Raw FASTQ data were processed as described previously [44 (link)]. RNA expression data of MDA-MB-453, MDA-MB-231 and MFUM-BrTNBC-1 (4th passage) were compared to the MCF-7 epithelial CL.
RNA was further analysed using RNA-seq variant calling pipeline. Raw reads were aligned to reference genome GRCh38 using STAR aligner [45 (link)]. PCR duplicates were marked and sorted using PicardTools v2.26.6 (broadinstitute.github.io/picard/; accessed on 13 December 2021. Subsequently, cigar reads spanning splice sites were split, and base quality scores were recalibrated using Genome Analysis Toolkit (GATK) (v4.2.3.0, Broad Institute, Cambridge, MA, USA) [46 (link)]. Variant calling was performed using HaplotypeCaller implemented in GATK with a minimum phred scaled confidence threshold of 20.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!